Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046746539> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2046746539 endingPage "30" @default.
- W2046746539 startingPage "25" @default.
- W2046746539 abstract "This multicenter randomized, double-blind, controlled study was performed to compare the efficacy and tolerability of chondroitin sulfate (CS, Condrosulf, IBSA, Lugano, CH) 1200 mg/day oral gel vs CS 3 x 400 mg/day capsules vs placebo, in patients with mono or bilateral knee osteoarthritis (Kellgren and Lawrence radiographic score grade I to III). A total of 127 patients, 40 of whom were treated with CS 1200 mg/day, 43 with CS 3 x 400 mg/day and 44 with placebo, were included in the statistical analysis of this 3-month treatment study. In the CS groups, Lequesne's Index and spontaneous joint pain (VAS) showed a significant reduction of clinical symptoms (P < 0.01 for both parameters), while only a slight reduction was observed in the placebo group (P = ns for Lequesne's Index and P < 0.05 for VAS). The physician's and patient's overall efficacy assessments were significantly in favour of the CS groups (P < 0.01). The treatment carried out with the three formulations was very well tolerated. In conclusion, these results indicate that CS favours the improvement of the subjective symptoms, improving the joint mobility. An additional consideration is that the efficacy of 1200 mg CS as a single daily dose does not differ from that of 3 x 400 mg daily doses of CS for all the clinical parameters taken into consideration." @default.
- W2046746539 created "2016-06-24" @default.
- W2046746539 creator A5001198256 @default.
- W2046746539 creator A5024020276 @default.
- W2046746539 creator A5030391011 @default.
- W2046746539 creator A5055275927 @default.
- W2046746539 creator A5067557995 @default.
- W2046746539 creator A5069978653 @default.
- W2046746539 date "1998-05-01" @default.
- W2046746539 modified "2023-10-05" @default.
- W2046746539 title "Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3×400 mg/day vs placebo" @default.
- W2046746539 cites W1977207093 @default.
- W2046746539 doi "https://doi.org/10.1016/s1063-4584(98)80008-3" @default.
- W2046746539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9743816" @default.
- W2046746539 hasPublicationYear "1998" @default.
- W2046746539 type Work @default.
- W2046746539 sameAs 2046746539 @default.
- W2046746539 citedByCount "105" @default.
- W2046746539 countsByYear W20467465392012 @default.
- W2046746539 countsByYear W20467465392013 @default.
- W2046746539 countsByYear W20467465392014 @default.
- W2046746539 countsByYear W20467465392015 @default.
- W2046746539 countsByYear W20467465392016 @default.
- W2046746539 countsByYear W20467465392017 @default.
- W2046746539 countsByYear W20467465392018 @default.
- W2046746539 countsByYear W20467465392019 @default.
- W2046746539 countsByYear W20467465392020 @default.
- W2046746539 countsByYear W20467465392021 @default.
- W2046746539 countsByYear W20467465392022 @default.
- W2046746539 countsByYear W20467465392023 @default.
- W2046746539 crossrefType "journal-article" @default.
- W2046746539 hasAuthorship W2046746539A5001198256 @default.
- W2046746539 hasAuthorship W2046746539A5024020276 @default.
- W2046746539 hasAuthorship W2046746539A5030391011 @default.
- W2046746539 hasAuthorship W2046746539A5055275927 @default.
- W2046746539 hasAuthorship W2046746539A5067557995 @default.
- W2046746539 hasAuthorship W2046746539A5069978653 @default.
- W2046746539 hasBestOaLocation W20467465391 @default.
- W2046746539 hasConcept C105702510 @default.
- W2046746539 hasConcept C126322002 @default.
- W2046746539 hasConcept C142724271 @default.
- W2046746539 hasConcept C153074725 @default.
- W2046746539 hasConcept C197934379 @default.
- W2046746539 hasConcept C204787440 @default.
- W2046746539 hasConcept C27081682 @default.
- W2046746539 hasConcept C2776164576 @default.
- W2046746539 hasConcept C2778375690 @default.
- W2046746539 hasConcept C2779553658 @default.
- W2046746539 hasConcept C3017583242 @default.
- W2046746539 hasConcept C42219234 @default.
- W2046746539 hasConcept C71924100 @default.
- W2046746539 hasConcept C90924648 @default.
- W2046746539 hasConceptScore W2046746539C105702510 @default.
- W2046746539 hasConceptScore W2046746539C126322002 @default.
- W2046746539 hasConceptScore W2046746539C142724271 @default.
- W2046746539 hasConceptScore W2046746539C153074725 @default.
- W2046746539 hasConceptScore W2046746539C197934379 @default.
- W2046746539 hasConceptScore W2046746539C204787440 @default.
- W2046746539 hasConceptScore W2046746539C27081682 @default.
- W2046746539 hasConceptScore W2046746539C2776164576 @default.
- W2046746539 hasConceptScore W2046746539C2778375690 @default.
- W2046746539 hasConceptScore W2046746539C2779553658 @default.
- W2046746539 hasConceptScore W2046746539C3017583242 @default.
- W2046746539 hasConceptScore W2046746539C42219234 @default.
- W2046746539 hasConceptScore W2046746539C71924100 @default.
- W2046746539 hasConceptScore W2046746539C90924648 @default.
- W2046746539 hasLocation W20467465391 @default.
- W2046746539 hasLocation W20467465392 @default.
- W2046746539 hasOpenAccess W2046746539 @default.
- W2046746539 hasPrimaryLocation W20467465391 @default.
- W2046746539 hasRelatedWork W1838036285 @default.
- W2046746539 hasRelatedWork W1966031956 @default.
- W2046746539 hasRelatedWork W1990986050 @default.
- W2046746539 hasRelatedWork W2019989482 @default.
- W2046746539 hasRelatedWork W2046746539 @default.
- W2046746539 hasRelatedWork W2068786447 @default.
- W2046746539 hasRelatedWork W2070522638 @default.
- W2046746539 hasRelatedWork W2118662627 @default.
- W2046746539 hasRelatedWork W2355198127 @default.
- W2046746539 hasRelatedWork W9372330 @default.
- W2046746539 hasVolume "6" @default.
- W2046746539 isParatext "false" @default.
- W2046746539 isRetracted "false" @default.
- W2046746539 magId "2046746539" @default.
- W2046746539 workType "article" @default.